Unraveling the Mechanisms of S100A8/A9 in Myocardial Injury and Dysfunction

被引:0
作者
Xu, Yuanbo [1 ]
Wang, Yixuan [1 ]
Ning, Ke [1 ]
Bao, Yimin [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Sch Integrat Med, 1200 Cailun Rd, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
myocardial damage; biomarker; inflammation; mitochondria; SIGNALING PATHWAY; RECEPTOR; 4; PROTEIN; S100; EXPRESSION; APOPTOSIS; INFLAMMATION; ACTIVATION; INFARCTION; MONOCYTES;
D O I
10.3390/cimb46090577
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
S100A8 and S100A9, which are prominent members of the calcium-binding protein S100 family and recognized as calprotectin, form a robust heterodimer known as S100A8/A9, crucial for the manifestation of their diverse biological effects. Currently, there is a consensus that S100A8/A9 holds promise as a biomarker for cardiovascular diseases (CVDs), exerting an influence on cardiomyocytes or the cardiovascular system through multifaceted mechanisms that contribute to myocardial injury or dysfunction. In particular, the dualistic nature of S100A8/A9, which functions as both an inflammatory mediator and an anti-inflammatory agent, has garnered significantly increasing attention. This comprehensive review explores the intricate mechanisms through which S100A8/A9 operates in cardiovascular diseases, encompassing its bidirectional regulatory role in inflammation, the initiation of mitochondrial dysfunction, the dual modulation of myocardial fibrosis progression, and apoptosis and autophagy. The objective is to provide new information on and strategies for the clinical diagnosis and treatment of cardiovascular diseases in the future.
引用
收藏
页码:9707 / 9720
页数:14
相关论文
共 106 条
  • [1] Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8
    Ahn, G-One
    Seita, Jun
    Hong, Beom-Ju
    Kim, Young-Eun
    Bok, Seoyeon
    Lee, Chan-Ju
    Kim, Kwang Soon
    Lee, Jerry C.
    Leeper, Nicholas J.
    Cooke, John P.
    Kim, Hak Jae
    Kim, Il Han
    Weissman, Irving L.
    Brown, J. Martin
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (07) : 2698 - 2703
  • [2] S100A8 and S100A9 in Cardiovascular Biology and Disease
    Averill, Michelle M.
    Kerkhoff, Claus
    Bornfeldt, Karin E.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 223 - 229
  • [3] Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy
    Bhardwaj, Gourav
    Doerr, Marcus
    Sappa, Praveen Kumar
    Ameling, Sabine
    Dhople, Vishnu
    Steil, Leif
    Klingel, Karin
    Empen, Klaus
    Beug, Daniel
    Voelker, Uwe
    Felix, Stephan B.
    Hammer, Elke
    [J]. JOURNAL OF PROTEOMICS, 2017, 150 : 121 - 129
  • [4] Salmonella pathogenicity island 1 knockdown confers protection against myocardial fibrosis and inflammation in uremic cardiomyopathy via down-regulation of S100 Calcium Binding Protein A8/A9 transcription
    Cai, Xinyong
    Hong, Lang
    Liu, Yuanyuan
    Huang, Xiao
    Lai, Hengli
    Shao, Liang
    [J]. RENAL FAILURE, 2022, 44 (01) : 1819 - 1832
  • [5] S100A8/A9 in Myocardial Infarction: A Promising Biomarker and Therapeutic Target
    Cai, ZhuLan
    Xie, Qingwen
    Hu, Tongtong
    Yao, Qi
    Zhao, Jinhua
    Wu, Qingqing
    Tang, Qizhu
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [6] S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12)
    Ceron, Jose Joaquin
    Ortin-Bustillo, Alba
    Lopez-Martinez, Maria Jose
    Martinez-Subiela, Silvia
    Eckersall, Peter David
    Tecles, Fernando
    Tvarijonaviciute, Asta
    Munoz-Prieto, Alberto
    [J]. BIOLOGY-BASEL, 2023, 12 (06):
  • [7] Alarmin S100A8 Activates Alveolar Epithelial Cells in the Content of Acute Lung Injury in a TLR4-Dependent Manner
    Chakraborty, Deblina
    Zenker, Stefanie
    Rossaint, Jan
    Hoelscher, Anna
    Pohlen, Michele
    Zarbock, Alexander
    Roth, Johannes
    Vogl, Thomas
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [8] S100A9 is a functional effector of infarct wall thinning after myocardial infarction
    Chalise, Upendra
    Becirovic-Agic, Mediha
    Daseke, Michael J.
    Konfrst, Shelby R.
    Rodriguez-Paar, Jocelyn R.
    Feng, Dan
    Salomon, Jeffrey D.
    Anderson, Daniel R.
    Cook, Leah M.
    Lindsey, Merry L.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2022, 322 (02): : H145 - H155
  • [9] Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
    Chapuis, Nicolas
    Ibrahimi, Nusaibah
    Belmondo, Thibaut
    Goulvestre, Claire
    Berger, Anne-Emmanuelle
    Mariaggi, Alice-Andree
    Andrieu, Muriel
    Chenevier-Gobeaux, Camille
    Bayle, Arnaud
    Campos, Lydia
    Cheurfa, Cherifa
    Chocron, Richard
    Diehl, Jean-Luc
    Doumenc, Benoit
    Duchemin, Jerome
    Duprat, Manon
    Francois, Fabien
    Gendron, Nicolas
    Mirault, Tristant
    Pene, Frederic
    Philippe, Aurelien
    Pommeret, Fanny
    Sanchez, Olivier
    Smadja, David M.
    Szwebel, Tali-Anne
    Silvin, Aymeric
    Ginhoux, Florent
    Lacroix, Ludovic
    Jules-Clement, Gerome
    Rapeteramana, Sarobidy
    Mavier, Colette
    Steller, Laura
    Perniconi, Barbara
    Andre, Fabrice
    Drubay, Damien
    Fontenay, Michaela
    Hue, Sophie
    Paul, Stephane
    Solary, Eric
    [J]. EBIOMEDICINE, 2022, 80
  • [10] Identification of S100A8/A9 involved in thromboangiitis obliterans development using tandem mass tags-labeled quantitative proteomics analysis
    Chen, Jing
    Chen, Chunfang
    Wang, Lili
    Feng, Xinyi
    Chen, Yinru
    Zhang, Rong
    Cheng, Yuanyuan
    Liu, Zhongqiu
    Chen, Qi
    [J]. CELLULAR SIGNALLING, 2024, 120